Learn / PCRX
NASDAQ: PCRX
Pacira BioSciences (PCRX) stock, explained like you're 5
Pacira BioSciences trades on the Nasdaq under the ticker PCRX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.4 billion dollars.
- Ticker
- PCRX
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 1.4 billion dollars
Is Pacira BioSciences a small, medium or large cap company?
No. Pacira BioSciences is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.4 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Pacira BioSciences makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves PCRX stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non Opioid Pain Therapies (Viatris Newsroom)
- What Pacira BioSciences Doubters Got Wrong (Simply Wall Street)
- Pacira BioSciences, Inc. Common Stock (Nasdaq:PCRX) Stock Quote (FinancialContent)
- Pacira BioSciences, Inc. (PCRX) Stock Forecasts (Yahoo Finance)
- Pacira BioSciences Stock Surges 44% on $1.7 Billion Viatris Acquisition (Barron's)
Follow PCRX in your daily brief
Each trading day at 5 PM ET we post what happened to Pacira BioSciences and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow PCRX
Questions about Pacira BioSciences stock
What does Pacira BioSciences do?
Pacira BioSciences trades on the Nasdaq under the ticker PCRX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.4 billion dollars.
What is the ticker symbol for Pacira BioSciences?
Pacira BioSciences trades under the ticker PCRX on the Nasdaq.
What is Pacira BioSciences's market cap?
Pacira BioSciences is a small cap stock with a market cap of about 1.4 billion dollars.
How does Pacira BioSciences make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves PCRX stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow PCRX stock every day?
Add PCRX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.